anti-Clostridium difficile toxin antibody (EPIcyte)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-Clostridium difficile toxin antibody (EPIcyte)
Drug Alias NameClostridium difficile therapy (EPIcyte)C difficile therapy (EPIcyte)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBacterial pathogenicity factor modulators
TargetsUpdating
Therapy Area/IndicationsDiarrheaClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEPIcyte Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEPIcyte Pharmaceutical IncMedarex Inc
Active IndicationsN/A
Inactive IndicationsDiarrheaClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A